Your browser doesn't support javascript.
loading
1,3-Substituted ß-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis.
Chen, Bei; Wu, Jianbing; Yan, Zhengsheng; Wu, Hongmei; Gao, Huijing; Liu, Yun; Zhao, Jun; Wang, Jianhua; Yang, Jianhua; Zhang, Yihua; Pan, Jingxuan; Ling, Yong; Wen, Hao; Huang, Zhangjian.
Afiliación
  • Chen B; State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, and College of Pharmaceutical Sciences, Xinjiang Medical University, Urumqi, Xinjiang 830054, P. R. China.
  • Wu J; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, P. R. China.
  • Yan Z; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, P. R. China.
  • Wu H; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong 226001, P. R. China.
  • Gao H; State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, and College of Pharmaceutical Sciences, Xinjiang Medical University, Urumqi, Xinjiang 830054, P. R. China.
  • Liu Y; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong 226001, P. R. China.
  • Zhao J; State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, and College of Pharmaceutical Sciences, Xinjiang Medical University, Urumqi, Xinjiang 830054, P. R. China.
  • Wang J; State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, and College of Pharmaceutical Sciences, Xinjiang Medical University, Urumqi, Xinjiang 830054, P. R. China.
  • Yang J; State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, and College of Pharmaceutical Sciences, Xinjiang Medical University, Urumqi, Xinjiang 830054, P. R. China.
  • Zhang Y; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, P. R. China.
  • Pan J; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, P. R. China.
  • Ling Y; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong 226001, P. R. China.
  • Wen H; State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, and College of Pharmaceutical Sciences, Xinjiang Medical University, Urumqi, Xinjiang 830054, P. R. China.
  • Huang Z; State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, and College of Pharmaceutical Sciences, Xinjiang Medical University, Urumqi, Xinjiang 830054, P. R. China.
J Med Chem ; 66(24): 16680-16693, 2023 12 28.
Article en En | MEDLINE | ID: mdl-38069814
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Echinococcus granulosus / Equinococosis Límite: Animals Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Echinococcus granulosus / Equinococosis Límite: Animals Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article